Rebody Health Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 9/10
Best for: semaglutide from $420.99/month
What Rebody Health does best is charge less than most of the register.
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
Prices are published up front: compounded semaglutide from about $199.99/mo and compounded tirzepatide from about $249.99/mo as weekly injections, with daily oral melt tablets and brand-name Wegovy and Zepbound also sold, and dose-based pricing shown before each refill. Compound Technologies Inc. operates the brand in 47 states, excluding Massachusetts, Rhode Island and Vermont. Rebody is not a pharmacy, and the licensed compounding pharmacies that prepare its prescriptions are not named on the site.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Vetted alternatives to Rebody Health
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Rebody Health at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $199.99/mo (Weekly compounded injection from $199.99/mo, dose-scaled higher as the prescription increases; daily oral 'melt' sema...)
- Pricing model
- Scales with dose — higher doses cost more
- What's included
- Medication · Consult
- Availability
- 47 states
- FDA status
- No FDA warning letter on record
How Rebody Health scores
Six columns, each one computed from something Rebody Health has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where it publishes nothing, that absence is what gets scored. Every seller in the register goes through the same six columns.
Value25%
10.0/10$420.99/month is 68% below the register median of $1299 for brand semaglutide.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, including the FDA-approved product. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10On the seller's own pages, a price is published before the questionnaire starts.
Trust & Safety15%
8.5/10does not name a dispensing pharmacy; shows a price before asking for health information; publishes its state list. Our verification confidence is high.
Accessibility10%
9.5/10Publishes coverage in 47 of 50 states.
Support10%
5.5/10The price covers medication, consult.
A seller that will not show a price before an intake loses points on Value and carries that note in its review. Withholding the number is itself a finding. How we score →
What we checked on Rebody Health
Last checked August 2026- Re-read the price on file across 4 dose or plan tiers
- Checked state coverage: all 50
- Established what the monthly figure covers, and what it leaves out
- Searched our FDA enforcement register for this operator
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below. Editorial confidence in this data: high.
What signing up with Rebody Health involves
Assembled from this seller’s entry in the register — the price record, the state list, the dispensing pharmacy where one is named, and what the monthly figure covers. It describes what a reader can expect to meet on the way to a prescription, and what is missing from the seller’s own disclosures. It is not a clinical judgment and not a prescribing decision.
- 1Rebody Health publishes a price on its own site before asking anything about you. You can compare it against this register without starting a questionnaire.
- 2The intake is a written questionnaire. No live video visit or baseline bloodwork is recorded as required.
- 3Rebody Health does not say which pharmacy dispenses the medication. That is common here and it means you cannot check the pharmacy's record before you buy.
- 4The monthly price is recorded as covering medication, consult.
- Cheapest standing monthly prices on record: semaglutide $420.99, tirzepatide $573.99. Membership fees, first-month rates and insured copays are excluded from those figures.
- Coverage is published for 47 of 50 states.
GLP-1 medications Rebody Health offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Pricing
Prices re-verified
Weekly compounded injection from $199.99/mo, dose-scaled higher as the prescription increases; daily oral 'melt' semaglutide from $143.99/mo. $50 off first month.
Weekly compounded injection from $249.99/mo, dose-scaled higher as the prescription increases; daily oral 'melt' tirzepatide from $249.99/mo.
Brand Wegovy weekly pen from $420.99/mo; Wegovy oral tablets from $343.99/mo.
Brand Zepbound KwikPen from $573.99/mo.
Check the price yourself before you pay
Every figure here was read off Rebody Health's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide at $420.99 a month, 68% below the $1299 median for the same drug and form across this register
- Tirzepatide at $573.99 a month, 54% below the $1249 median for the same drug and form across this register
- Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- The monthly figure covers medication and consult
- Coverage is published for 47 states
- No FDA warning letter matched this operator when we searched our enforcement register
Against it
- No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Rebody Health charges
Rebody Health lists $199.99/month. That sits above the middle of the market, which puts the burden on whatever else is in the package.
- Compounded semaglutide — $199.99/month
- Compounded tirzepatide — $249.99/month
- Brand-name semaglutide — $420.99/month
- Brand-name tirzepatide — $573.99/month
The median standing price across the GLP-1 providers we track is about $169/month, so this is a premium, and a premium has to buy something. Check what is bundled before accepting it.
Breeze Meds dispenses semaglutide and tirzepatide from $199/month, which makes it the honest comparison to run before committing here.
What Rebody Health dispenses
Rebody Health prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two best-evidenced weight-loss molecules currently on the market. You can take the approved brand pen or the cheaper compounded preparation. What separates them is review: the approved product went through it, the compounded one did not, and that is the whole of the trade.
A needle-free oral option is genuinely uncommon and is the reason some readers will look at Rebody Health at all. Set expectations on the evidence, though: the published weight-loss trials for these molecules used injections. Oral and sublingual delivery of peptides is far less studied, so treat it as a route that solves the needle problem rather than as a demonstrated equal to the shot.
What we could verify
On the record: it treats patients in all 50 states. We searched the federal warning-letter record for this operator and came back with nothing. Because the medication is compounded and no dispensing pharmacy is named publicly, the single most useful question to ask at intake is which licensed pharmacy fills the prescription. A seller that will not answer that has told you something. How we weigh oversight, disclosure and price evidence is set out in our scoring methodology.
Who should look elsewhere
- You are optimizing for the twelve-month total rather than the first bill — a flat-rate seller such as CoreAge Rx will usually win that arithmetic.
- You need to bill insurance. Like most of this market, this is cash-pay.
It fits if
- injections are the thing keeping you from starting
- you need access regardless of where you live
Our read
Rebody Health costs more than the middle of this market, and the oral option is the clearest thing that premium buys. If the extras it charges for are ones you would actually use, that is a defensible trade. If not, the same molecule is available for less.
The Bottom Line
What Rebody Health does best is charge less than most of the register.
Before you pay Rebody Health
Starting at $199.99/month. Check today's price, then book the free consultation.
Where Rebody Health is the wrong choice
No seller in this register suits every reader, and saying otherwise would be the easiest way to sell one. On these four counts another entry does better.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Rebody Health review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of August 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Rebody Health's current pricing
Plans start at $199.99/month. The free consultation is where you learn whether you qualify, and what it costs today.